We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,611

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPT
1976
PUT
Medical Properties Trust
MPT
$2.5B
$20.9M ﹤0.01%
3,571,800
+782,200
+28% +$3.86M
ARCH
1977
CALL
DELISTED
Arch Resources, Inc.
ARCH
$20.8M ﹤0.01%
150,700
+73,500
+95% +$10.1M
FTDR icon
1978
CALL
Frontdoor
FTDR
$5.96B
$20.8M ﹤0.01%
433,800
-138,600
-24% -$6.01M
SYRE icon
1979
Spyre Therapeutics
SYRE
$9.14B
$20.8M ﹤0.01%
707,586
EFX icon
1980
CALL
Equifax
EFX
$21.2B
$20.8M ﹤0.01%
70,700
-15,300
-18% -$4.32M
TNGX icon
1981
Tango Therapeutics
TNGX
$4.32B
$20.7M ﹤0.01%
2,694,125
+1,462,368
+119% +$14M
NICE icon
1982
Nice
NICE
$5.99B
$20.7M ﹤0.01%
119,331
-119,518
-50% -$20.5M
BAX icon
1983
CALL
Baxter International
BAX
$13.8B
$20.7M ﹤0.01%
544,800
+182,900
+51% +$6.72M
ODD icon
1984
PUT
ODDITY Tech
ODD
$605M
$20.7M ﹤0.01%
512,000
+179,800
+54% +$6.93M
CASY icon
1985
PUT
Casey's General Stores
CASY
$31.3B
$20.7M ﹤0.01%
55,000
+1,400
+3% +$524K
SMAR
1986
DELISTED
Smartsheet Inc.
SMAR
$20.6M ﹤0.01%
372,626
+109,321
+42% +$5.3M
CRS icon
1987
CALL
Carpenter Technology
CRS
$27.1B
$20.6M ﹤0.01%
129,200
+18,300
+17% +$2.48M
ACH
1988
Accendra Health
ACH
$73.1M
$20.6M ﹤0.01%
+1,313,398
New +$19.9M
RLAY icon
1989
Relay Therapeutics
RLAY
$4.35B
$20.6M ﹤0.01%
2,909,371
+1,746,035
+150% +$13M
VRSN icon
1990
CALL
VeriSign
VRSN
$25.7B
$20.6M ﹤0.01%
108,300
+34,400
+47% +$6.2M
CBT icon
1991
Cabot Corp
CBT
$4.54B
$20.5M ﹤0.01%
183,842
-44,126
-19% -$4.4M
MTDR icon
1992
PUT
Matador Resources
MTDR
$6.64B
$20.5M ﹤0.01%
415,000
+148,500
+56% +$8.36M
FE icon
1993
FirstEnergy
FE
$27.4B
$20.5M ﹤0.01%
461,877
+201,981
+78% +$8.5M
CPB icon
1994
PUT
Campbell Soup
CPB
$6.91B
$20.5M ﹤0.01%
418,400
-36,500
-8% -$1.78M
JEF icon
1995
CALL
Jefferies Financial Group
JEF
$12.7B
$20.5M ﹤0.01%
332,300
+200,100
+151% +$11.4M
INSM icon
1996
PUT
Insmed
INSM
$27B
$20.4M ﹤0.01%
279,300
-36,500
-12% -$2.69M
NTR icon
1997
CALL
Nutrien
NTR
$32.6B
$20.4M ﹤0.01%
424,100
+72,300
+21% +$3.49M
NTLA icon
1998
Intellia Therapeutics
NTLA
$1.67B
$20.3M ﹤0.01%
989,439
+226,759
+30% +$5.23M
SHOP icon
1999
Shopify
SHOP
$199B
$20.3M ﹤0.01%
253,627
-1,091,700
-81% -$75.4M
AVAV icon
2000
PUT
AeroVironment
AVAV
$9.76B
$20.3M ﹤0.01%
101,300
-65,600
-39% -$11.8M

Similar funds

Ken Griffin's Q3 2024 Portfolio in Review

As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Ken Griffin opened 1,614 new positions and closed 1,611 in Q3 2024.
  • Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.